EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ASIA Syndrome: State-of-the-Art and Future Perspectives

Mario Caldarelli iD, Pierluigi Rio iD, Vincenzo Giambra iD, Antonio Gasbarrini iD, Giovanni Gambassi, Rossella Cianci iD

Vaccines · 17.10.2024 · 12 (10) · 1183

DOI: 10.3390/vaccines12101183 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 17.10.2024. Verfasst von Mario Caldarelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expression “Autoimmune/inflammatory syndrome induced by adjuvants (ASIA)” was coined by Shoenfeld and colleagues in 2011. It defines a group of immune-mediated disorders that arise in people, with a genetic predisposition, following exposure to adjuvant agents. This syndrome has been reported after contact with silicone implants, medications, infections, metals, vaccines, and other substances. It typically occurs in individuals with a genetic predisposition, particularly involving genes, such as HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) and PTPN22 (protein tyrosine phosphatase non-receptor type 22). Some stimuli lead to an overactivation of the immune system, prompt the production of autoantibodies, and finally cause autoimmune disorders. This narrative review aims to provide an overview of the ASIA syndrome with a special focus on the role of adjuvants in different vaccines, especially after the COVID-19 pandemic, and insights into development of new treatments.

Schlagwörter

Stichwörter der Autor:innen

ASIAadjuvantsgenetic predispositionimmune systemvaccines

Autor:innen und Institutionen

  • Department of Translational Medicine and Surgery, Catholic University of Sacred Heart, 00168 Rome, Italy.
  • Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy.
  • Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies (ISBReMIT), Fondazione IRCCS "Casa Sollievo della Sofferenza", 71013 San Giovanni Rotondo, Italy.

ORCID-Profile: Mario Caldarelli, Pierluigi Rio, Vincenzo Giambra, Antonio Gasbarrini, Rossella Cianci

Zitieren

APA

Caldarelli, M., Rio, P., Giambra, V., Gasbarrini, A., Gambassi, G., & Cianci, R. (2024). ASIA Syndrome: State-of-the-Art and Future Perspectives. Vaccines, 12(10), 1183. https://doi.org/10.3390/vaccines12101183

Vancouver

Caldarelli M, Rio P, Giambra V, Gasbarrini A, Gambassi G, Cianci R. ASIA Syndrome: State-of-the-Art and Future Perspectives. Vaccines. 2024;12(10):1183. doi:10.3390/vaccines12101183

BibTeX
@article{Caldarelli2024,
  author = {Caldarelli, Mario and Rio, Pierluigi and Giambra, Vincenzo and Gasbarrini, Antonio and Gambassi, Giovanni and Cianci, Rossella},
  title = {ASIA Syndrome: State-of-the-Art and Future Perspectives},
  journal = {Vaccines},
  year = {2024},
  volume = {12},
  number = {10},
  pages = {1183},
  doi = {10.3390/vaccines12101183}
}
Kostenlos starten →